SVRA · Savara Inc

$5.49 -0.09 (-1.61%) At close · Aug 20

Market Cap

$1.11B

205.46M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Pauls	Chief Executive Officer	$660,000	—	$3,870,000	—	$297,000	$18,000	$4,845,000
Yasmine Wasfi	Chief Medical Officer	$476,728	—	$1,691,850	$246,742	$186,850	$18,000	$2,620,170
David Lowrance	Chief Financial & Administrative Officer & Secretary	$471,000	—	$1,612,500	—	$176,625	$18,000	$2,278,125
Robert Lutz	Chief Operating Officer	$471,000	—	$1,612,500	—	$176,625	$18,000	$2,278,125

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Pauls	Chief Executive Officer	$620,000	$31,000	$1,340,000	$2,593,011	$310,000	$18,000	$4,912,011
David Lowrance	Chief Financial & Administrative Officer & Secretary	$455,063	$18,203	$335,000	$864,337	$182,025	$18,000	$1,872,628
Robert Lutz	Chief Operating Officer	$454,480	$18,179	$335,000	$864,337	$181,792	$18,000	$1,871,788

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Pauls	Chief Executive Officer	$595,000	$59,500	$2,002,500	$787,223	$297,500	$18,000	$3,759,723
Robert Lutz	Chief Operating Officer	$387,341	$143,405	$1,066,200	$874,534	$174,800	$18,000	$2,664,280
David Lowrance	Chief Financial & Administrative Officer & Secretary	$437,561	$32,817	$712,000	$139,951	$175,025	$22,000	$1,519,354

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Pauls	Chief Executive Officer	$580,000	—	$490,750	$810,255	$290,000	$24,537	$2,195,542
David Lowrance	Chief Financial & Administrative Officer & Secretary	$416,725	$8,335	$151,000	$289,377	$166,690	$22,000	$1,054,127
Raymond Pratt	Chief Medical Officer	$65,621	—	$214,500	$392,301	$26,268	—	$698,690

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Pauls	Chief Executive Officer	$560,000	—	$444,000	$285,545	$329,000	$21,813	$1,640,358
Badrul Chowdhury	Chief Medical Officer	$540,750	—	$138,750	$81,584	$258,209	$18,000	$1,037,293
David Lowrance	Chief Financial & Administrative Officer & Secretary	$395,000	—	$138,750	$81,584	$188,613	$22,000	$825,947

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Matthew Pauls	Chief Executive Officer	$169,697	—	$299,999	$1,352,163	$74,648	$39,796	$1,936,303
Badrul Chowdhury	Chief Medical Officer	$525,000	—	—	$259,448	$223,493	$18,000	$1,025,941
David Lowrance	Chief Financial Officer & Secretary	$379,600	—	—	$245,296	$161,596	$22,000	$808,492

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Neville	Chief Executive Officer	$546,000	—	—	$240,941	$238,875	$22,000	$1,047,816
Taneli Jouhikainen	Chief Operating Officer & President	$546,000	—	—	$240,941	$201,338	$22,000	$1,010,279
David Lowrance	Chief Financial Officer & Secretary	$379,600	—	—	$180,706	$116,727	$22,000	$699,033

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Neville	Chief Executive Officer	$525,000	—	—	$3,342,724	$225,750	$22,000	$4,115,474
Taneli Jouhikainen	Chief Operating Officer & President	$525,000	—	—	$3,133,803	$204,094	$22,000	$3,884,897
David Lowrance	Chief Financial Officer & Secretary	$365,000	—	—	$1,671,362	$116,891	$22,000	$2,175,253

Executive changes

Person	Role	Change	Effective	Filed
David Lowrance	Chief Financial and Administrative Officer	Resigned	2026-07-15	2026-06-08
Robert Lutz	Chief Financial and Operating Officer	Appointed	2026-07-15	2026-06-08
Robert Lutz	Chief Operating Officer	Appointed	2023-02-13	2023-02-14
Dave Lowrance	Chief Financial and Administrative Officer	Appointed	2022-12-13	2022-12-15
Dr. Badrul Chowdhury	Chief Medical Officer	Resigned	2022-09-09	2022-08-26
Matthew Pauls	Chief Executive Officer	Appointed	2020-12-08	2020-12-10
Taneli Jouhikainen	President and Chief Business Officer	Resigned	—	2020-09-11
Rob Neville	member of the Board	Resigned	2020-09-11	2020-09-11
Taneli Jouhikainen	President and Chief Business Officer	Resigned	2020-09-11	2020-09-11
Rob Neville	Chief Executive Officer	Resigned	2020-09-11	2020-09-11
Matthew Pauls	Interim Chief Executive Officer	Appointed	2020-09-11	2020-09-11
Matthew Pauls	Chairman	Appointed	2020-09-11	2020-09-11

Key facts CIK 1160308 CUSIP 805111101 13F (30d) 186 filings 174 filers Visit website Investor relations